Home LiteratureArticle Details
PMID: 7497446 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't

Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32).

Cancer genetics and cytogenetics ·Vol. 84 ·No. 1 ·1995-10-01 ·Pages 69-72

Kobayashi H, Kitano K, Saito H, Aoki K, Narita A, Terada N, Sonoyama M, Uchimaru K, Machii T, Motokura T

Abstract

Prolymphocytic leukemia (PLL) was diagnosed by morphologic and immunophenotypical studies in a 72-year-old Japanese man. Massive splenomegaly was present but lymphadenopathy was minimal in this case. Chromosomal analysis of peripheral mononuclear cells showed t(11;14)(q13;q32) in all metaphases examined, except for one normal karyotype. Northern blot analysis of RNA prepared from leukemic cells obtained from the patient revealed overexpression of the PRAD1/cyclin D1 proto-oncogene, which has not been described previously in patients with PLL.

MeSH Terms
Aged Chromosomes, Human, Pair 11 Chromosomes, Human, Pair 14 Cyclin D1 Cyclins/genetics Humans Leukemia, Prolymphocytic/genetics Male Oncogene Proteins/genetics Oncogenes Proto-Oncogene Mas Translocation, Genetic
Chemicals
Cyclins MAS1 protein, human Oncogene Proteins Proto-Oncogene Mas Cyclin D1
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Kobayashi H
Department of Internal Medicine, Nagano Red Cross Hospital, Japan.
Kitano K
Saito H
Aoki K
Narita A
Terada N
Sonoyama M
Uchimaru K
Machii T
Motokura T
Article Info
Journal
Cancer genetics and cytogenetics
Abbr.
Cancer Genet Cytogenet
ISSN
0165-4608
Published
1995-10-01
Pages
69-72
Language
English
Region
United States
NLM ID
7909240
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com